⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11752553 | 0.88 | — | — | |
| SCHEMBL3657848 | 0.73 | — | — | |
| SCHEMBL4576510 | 0.71 | — | — | |
| SCHEMBL2360832 | 0.65 | — | — | |
| SCHEMBL2360831 | 0.65 | — | — | |
| SCHEMBL19873 | 0.61 | — | — | |
| SCHEMBL7659872 | 0.61 | — | — | |
| Methane SCHEMBL15227989 | 0.59 | — | — | |
| Bromide SCHEMBL30480806 | 0.59 | — | — | |
| SCHEMBL30449161 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109354497-B | Ho-doped transparent scandium oxide ceramic and preparation method thereof | INST. OF CHEMICAL MATERIAL, CHINA ACADEMY OF ENGINEERING PHYSICS (CN) | 2021-06-22 | — | — | CN | claimed |
| US-20200330654-A1 | Degradable Removable Implant for the Sustained Release of An Active Compound | JANSSEN SCIENCES IRELAND UNLIMITED CO (IE) | 2020-10-22 | — | — | US | claimed |
| US-20140296799-A1 | Degradable Removable Implant for the Sustained Release of An Active Compound | Janssen Sciences Ireland Unlimited Company (IE) | 2014-10-02 | — | — | US | claimed |
| US-8784858-B2 | Degradable removable implant for the sustained release of an active compound | JANSSEN R&D IRELAND (IE) | 2014-07-22 | — | — | US | claimed |
| US-20040043943-A1 | Method for the management of incontinence | ALZA CORPORATION | 2004-03-04 | — | — | US | claimed |
| US-20040037881-A1 | Method for the management of incontinence | ALZA CORPORATION | 2004-02-26 | — | — | US | claimed |
| US-6262115-B1 | ADMITTING ORALLY INTO THE PATIENT A DOSAGE FORM OF OXYBUTYNIN AND ITS PHARMACEUTICALLY ACCEPTABLE SALT, THAT IS ADMINISTERED ONCE-A-DAY AS SUSTAINED-RELEASE FORM FOR MANAGEMENT OF INCONTINENCE | ALZA COPORATION | 2001-07-17 | — | — | US | claimed |
| US-20010005728-A1 | Method for the management of incontinence | ALZA CORPORATION | 2001-06-28 | — | — | US | claimed |
| US-20260000691-A1 | COMPOUNDS, METHODS, AND TREATMENTS FOR ABNORMAL SIGNALING PATHWAYS FOR PRENATAL AND POSTNATAL DEVELOPMENT | JENNINGS BARBARA BROOKE (US) | 2026-01-01 | — | — | US | disclosed |
| US-12435055-B2 | 3-methylideneoxan-4-one compounds and substituted derivates thereof as inhibitors of telomerase | NORTHWESTERN UNIVERSITY (US) | 2025-10-07 | — | — | US | disclosed |
| US-20250241554-A1 | Magnetic Marker for Surgical Localization | ENDOMAGNETICS LTD (GB) | 2025-07-31 | — | — | US | disclosed |
| US-12329766-B2 | Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development | JENNINGS BARBARA BROOKE (US) | 2025-06-17 | — | — | US | disclosed |
| US-12252477-B2 | Applications of known and novel cannabinoids | BESSOR PHARMA, LLC (US) | 2025-03-18 | — | — | US | disclosed |
| US-20250064548-A1 | Marker Materials and Forms for Magnetic Marker Localization (MML) | ENDOMAGNETICS LTD (GB) | 2025-02-27 | — | — | US | disclosed |
| US-5998485-A | DOSE DEPENDENT | CEDARS-SINAI MEDICAL CENTER (US) | 1999-12-07 | — | — | US | disclosed |
| EP-0724429-B1 | COMPOSITION AND METHOD FOR DELIVERY OF DRUGS | ADVANCED RES & TECH INST (US) | 1999-07-07 | — | — | EP | disclosed |
| WO-1998057620-A2 | INOSITOL FOR MODULATION OF IMMUNE RESPONSE | CEDARS-SINAI MEDICAL CENTER (US) | 1998-12-23 | — | — | WO | disclosed |
| EP-0724429-A1 | COMPOSITION AND METHOD FOR DELIVERY OF DRUGS | INDIANA UNIVERSITY FOUNDATION (US) | 1996-08-07 | — | — | EP | disclosed |
| US-5171217-A | Injecting drug carried on microparticles of biocompatible biodegradable polymer into vessel wall under directed pressure | INDIANA UNIVERSITY FOUNDATION (US) | 1992-12-15 | — | — | US | disclosed |
| WO-1992015282-A2 | COMPOSITION AND METHOD FOR DELIVERY OF DRUGS | INDIANA UNIVERSITY FOUNDATION (US) | 1992-09-17 | — | — | WO | disclosed |